Surgical Management of Chiari Malformation Type I in the Pediatric Population: A Single-Center Experience

Maria Sole Venanzi1,2, Marco Pavanello2, Mattia Pacetti2

  • 1Neurosurgery Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.

PubMed

Insights

This study on Chiari malformation type 1 (CM-1) and type 1.5 (CM-1.5) in pediatric patients found that posterior fossa decompression is key. Intraoperative ultrasound aids surgical strategy for cerebrospinal fluid (CSF) flux, though quantitative measures need refinement.

Area of Science:

  • Neurosurgery
  • Pediatric Neurology
  • Medical Imaging

Background:

  • Chiari malformation type 1 (CM-1) is characterized by cerebellar tonsil descent below the foramen magnum.
  • Chiari malformation type 1.5 (CM-1.5) involves herniation of both cerebellar tonsils and the brainstem.
  • Common symptoms include headaches and cervical pain, often co-occurring with syringomyelia and hydrocephalus.

Purpose of the Study:

  • To retrospectively analyze pediatric patients with CM-1 and CM-1.5.
  • To evaluate surgical interventions and outcomes for these conditions.
  • To assess the utility of intraoperative ultrasonography in guiding surgical strategy.

Main Methods:

  • Retrospective analysis of pediatric patients with CM-1 and CM-1.5 from 2006-2020.
  • Inclusion of demographic, radiological, surgical, and outcome data.
  • Utilization of intraoperative ultrasonography to guide surgical interventions.

Main Results:

  • 83.9% CM-1 and 16.1% CM-1.5 diagnoses among 211 surgically treated patients.
  • Headaches (69%) and cerebellar signs (29%) were prevalent symptoms.
  • Syringomyelia (28.4%) and hydrocephalus (8%) were significant comorbidities.

Conclusions:

  • Posterior cranial fossa decompression is the primary surgical treatment for CM-1/CM-1.5.
  • The choice between bony decompression and duraplasty remains debated in pediatric cases.
  • Intraoperative ultrasound can assist in real-time surgical decision-making for CSF flux restoration, requiring further quantitative validation.

Related Concept Videos